Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 643

1.

High-phosphate induced vascular calcification is reduced by iron citrate through inhibition of extracellular matrix osteo-chondrogenic shift in VSMCs.

Ciceri P, Falleni M, Tosi D, Martinelli C, Bulfamante G, Block GA, Messa P, Cozzolino M.

Int J Cardiol. 2019 Oct 8. pii: S0167-5273(19)32387-3. doi: 10.1016/j.ijcard.2019.09.068. [Epub ahead of print]

PMID:
31619363
2.

Seawalls at Work: Envirotech and Labor on the North Sea Coast before 1800.

Soens T, De Block G, Jongepier I.

Technol Cult. 2019;60(3):688-725. doi: 10.1353/tech.2019.0070.

PMID:
31422963
3.

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.

Rossing P, Block GA, Chin MP, Goldsberry A, Heerspink HJL, McCullough PA, Meyer CJ, Packham D, Pergola PE, Spinowitz B, Sprague SM, Warnock DG, Chertow GM.

Kidney Int. 2019 Oct;96(4):1030-1036. doi: 10.1016/j.kint.2019.04.027. Epub 2019 May 16.

PMID:
31377056
4.

Efficacy of intravenous administration of apomorphine for removal of gastric foreign material in dogs: 495 cases (2010-2015).

Kirchofer KS, Block G, Johnson JA.

J Am Vet Med Assoc. 2019 Aug 15;255(4):459-465. doi: 10.2460/javma.255.4.459.

PMID:
31355726
5.

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients.

Cunningham J, Block GA, Chertow GM, Cooper K, Evenepoel P, Iles J, Sun Y, Ureña-Torres P, Bushinsky DA.

Kidney Int Rep. 2019 Apr 16;4(7):987-994. doi: 10.1016/j.ekir.2019.04.010. eCollection 2019 Jul.

6.

Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2-lessons from evolution, the animal kingdom and rare progeroid syndromes.

Stenvinkel P, Meyer CJ, Block GA, Chertow GM, Shiels PG.

Nephrol Dial Transplant. 2019 Jul 13. pii: gfz120. doi: 10.1093/ndt/gfz120. [Epub ahead of print]

PMID:
31302696
7.

A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.

Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, Chertow GM.

J Am Soc Nephrol. 2019 Aug;30(8):1495-1504. doi: 10.1681/ASN.2018101016. Epub 2019 Jul 5.

PMID:
31278194
8.

Test-Retest Reliability of the Effects of Continuous Theta-Burst Stimulation.

Jannati A, Fried PJ, Block G, Oberman LM, Rotenberg A, Pascual-Leone A.

Front Neurosci. 2019 May 17;13:447. doi: 10.3389/fnins.2019.00447. eCollection 2019.

9.

Erratum.

Bushinsky DA, Chertow GM, Cheng S, Deng H, Kopyt N, Martin KJ, Rastogi A, Ureña-Torres P, Vervloet M, Block GA.

Nephrol Dial Transplant. 2019 May 15. pii: gfz111. doi: 10.1093/ndt/gfz111. [Epub ahead of print] No abstract available.

PMID:
31093680
10.

Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.

Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M.

J Am Soc Nephrol. 2019 Jun;30(6):1096-1108. doi: 10.1681/ASN.2018101058. Epub 2019 May 13.

PMID:
31085679
11.

Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.

Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, Smith ER, Pasch A, Isakova T; CRIC Study Investigators.

Am J Kidney Dis. 2019 Jun;73(6):806-814. doi: 10.1053/j.ajkd.2019.01.024. Epub 2019 Mar 29.

PMID:
30935773
12.

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.

Block GA, Chertow GM, Sullivan JT, Deng H, Mather O, Tomlin H, Serenko M.

PLoS One. 2019 Mar 15;14(3):e0213774. doi: 10.1371/journal.pone.0213774. eCollection 2019.

13.

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.

Bushinsky DA, Chertow GM, Cheng S, Deng H, Kopyt N, Martin KJ, Rastogi A, Ureña-Torres P, Vervloet M, Block GA.

Nephrol Dial Transplant. 2019 Mar 11. pii: gfz039. doi: 10.1093/ndt/gfz039. [Epub ahead of print] Erratum in: Nephrol Dial Transplant. 2019 May 15;:.

PMID:
30859218
14.

Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial.

Block GA, Rosenbaum DP, Yan A, Chertow GM.

J Am Soc Nephrol. 2019 Apr;30(4):641-652. doi: 10.1681/ASN.2018080832. Epub 2019 Mar 7.

PMID:
30846557
15.

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety.

Lee E, Gibbs JP, Emery MG, Block G, Wasserman SM, Hamilton L, Kasichayanula S, Hanafin P, Somaratne R, Egbuna O.

Clin Pharmacol Drug Dev. 2019 Apr;8(3):281-289. doi: 10.1002/cpdd.650. Epub 2019 Jan 24.

16.

Barriers and next steps to providing a spectrum of effective health care to companion animals.

Stull JW, Shelby JA, Bonnett BN, Block G, Budsberg SC, Dean RS, Dicks MR, Forsgren BW, Golab GC, Hamil JA, Kass PH, King LJ, Lund EM, Maddux ML, McFarland JM, McKenzie BA, Moyer MR, Olson PN, Wittum TE.

J Am Vet Med Assoc. 2018 Dec 1;253(11):1386-1389. doi: 10.2460/javma.253.11.1386. No abstract available.

PMID:
30451620
17.

Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.

Prasad PV, Li W, Raj DS, Carr J, Carr M, Thacker J, Li LP, Wang C, Sprague SM, Ix JH, Chonchol M, Block G, Cheung AK, Raphael K, Gassman J, Wolf M, Fried LF, Isakova T; CKD Optimal Management with BInders and NicotinamidE (COMBINE) study group.

Kidney Int Rep. 2018 Jul 7;3(6):1467-1472. doi: 10.1016/j.ekir.2018.07.006. eCollection 2018 Nov. No abstract available.

18.

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.

Block GA, Pergola PE, Fishbane S, Martins JG, LeWinter RD, Uhlig K, Neylan JF, Chertow GM.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1115-1124. doi: 10.1093/ndt/gfy318.

19.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease.

Chertow GM, Appel GB, Block GA, Chin MP, Coyne DW, Goldsberry A, Kalantar-Zadeh K, Meyer CJ, Molitch ME, Pergola PE, Raskin P, Silva AL, Spinowitz B, Sprague SM, Rossing P.

J Diabetes Complications. 2018 Dec;32(12):1113-1117. doi: 10.1016/j.jdiacomp.2018.09.005. Epub 2018 Sep 13.

20.

Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.

Whittaker DS, Loh DH, Wang HB, Tahara Y, Kuljis D, Cutler T, Ghiani CA, Shibata S, Block GD, Colwell CS.

J Biol Rhythms. 2018 Oct;33(5):535-554. doi: 10.1177/0748730418790401. Epub 2018 Aug 7.

PMID:
30084274
21.

A new look at standard of care.

Block G.

J Am Vet Med Assoc. 2018 Jun 1;252(11):1343-1344. doi: 10.2460/javma.252.11.1343. No abstract available.

PMID:
29772971
22.

Effects of calcimimetics on long-term outcomes in dialysis patients: literature review and Bayesian meta-analysis.

Lozano-Ortega G, Waser N, Bensink ME, Goring S, Bennett H, Block GA, Chertow GM, Trotman ML, Cooper K, Levy AR, Belozeroff V.

J Comp Eff Res. 2018 Jul;7(7):693-707. doi: 10.2217/cer-2018-0015. Epub 2018 May 15.

PMID:
29762046
23.

The phosphate bucket list.

Isakova T, Block G.

Kidney Int. 2018 May;93(5):1033-1035. doi: 10.1016/j.kint.2018.01.010.

PMID:
29680017
24.

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.

Haase VH, Chertow GM, Block GA, Pergola PE, deGoma EM, Khawaja Z, Sharma A, Maroni BJ, McCullough PA.

Nephrol Dial Transplant. 2019 Jan 1;34(1):90-99. doi: 10.1093/ndt/gfy055.

25.

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.

Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):339-346. doi: 10.1093/ndt/gfy061.

26.

Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.

Pergola PE, Fishbane S, LeWinter RD, Neylan JF, Uhlig K, Block GA, Chertow GM.

Am J Hematol. 2018 Jun;93(6):E154-E156. doi: 10.1002/ajh.25088. Epub 2018 Mar 30. No abstract available.

27.

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.

PMID:
29459980
28.

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.

Chin MP, Bakris GL, Block GA, Chertow GM, Goldsberry A, Inker LA, Heerspink HJL, O'Grady M, Pergola PE, Wanner C, Warnock DG, Meyer CJ.

Am J Nephrol. 2018;47(1):40-47. doi: 10.1159/000486398. Epub 2018 Jan 18.

29.

Excitatory GABAergic Action and Increased Vasopressin Synthesis in Hypothalamic Magnocellular Neurosecretory Cells Underlie the High Plasma Level of Vasopressin in Diabetic Rats.

Kim YB, Kim WB, Jung WW, Jin X, Kim YS, Kim B, Han HC, Block GD, Colwell CS, Kim YI.

Diabetes. 2018 Mar;67(3):486-495. doi: 10.2337/db17-1042. Epub 2017 Dec 6.

30.

The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.

Malhotra R, Katz R, Hoofnagle A, Bostom A, Rifkin DE, Mcbride R, Probstfield J, Block G, Ix JH.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):36-44. doi: 10.2215/CJN.05440517. Epub 2017 Dec 5.

31.

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease.

Chertow GM, Block GA, Neylan JF, Pergola PE, Uhlig K, Fishbane S.

PLoS One. 2017 Nov 29;12(11):e0188712. doi: 10.1371/journal.pone.0188712. eCollection 2017.

32.

Association Between Anemia and Fatigue in Hospitalized Patients: Does the Measure of Anemia Matter?

Prochaska MT, Newcomb R, Block G, Park B, Meltzer DO.

J Hosp Med. 2017 Nov;12(11):898-904. doi: 10.12788/jhm.2832. Epub 2017 Sep 6.

33.

Interindividual variability in response to continuous theta-burst stimulation in healthy adults.

Jannati A, Block G, Oberman LM, Rotenberg A, Pascual-Leone A.

Clin Neurophysiol. 2017 Nov;128(11):2268-2278. doi: 10.1016/j.clinph.2017.08.023. Epub 2017 Sep 21.

34.

A Lifestyle Intervention via Email in Minority Breast Cancer Survivors: Randomized Parallel-Group Feasibility Study.

Paxton RJ, Hajek R, Newcomb P, Dobhal M, Borra S, Taylor WC, Parra-Medina D, Chang S, Courneya KS, Block G, Block T, Jones LA.

JMIR Cancer. 2017 Sep 21;3(2):e13. doi: 10.2196/cancer.7495.

35.

Variation in Sodium Intake and Intra-individual Change in Blood Pressure in Chronic Kidney Disease.

Pathak CM, Ix JH, Anderson CAM, Woodell TB, Smits G, Persky MS, Block GA, Rifkin DE.

J Ren Nutr. 2018 Mar;28(2):125-128. doi: 10.1053/j.jrn.2017.07.002. Epub 2017 Aug 31.

36.

Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Jovanovich A, Isakova T, Block G, Stubbs J, Smits G, Chonchol M, Miyazaki M.

Am J Kidney Dis. 2018 Jan;71(1):27-34. doi: 10.1053/j.ajkd.2017.06.017. Epub 2017 Aug 9.

37.

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it matters.

Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB.

Kidney Int. 2017 Jul;92(1):26-36. doi: 10.1016/j.kint.2017.04.006. Review. Erratum in: Kidney Int. 2017 Dec;92(6):1558.

38.

Dosing of Etelcalcetide vs Cinacalcet for Secondary Hyperparathyroidism-Reply.

Block GA, Chertow GM.

JAMA. 2017 May 23;317(20):2132-2133. doi: 10.1001/jama.2017.4746. No abstract available.

PMID:
28535231
39.

Overstimulated Consumers or Next-Generation Learners? Parent Tensions About Child Mobile Technology Use.

Radesky JS, Eisenberg S, Kistin CJ, Gross J, Block G, Zuckerman B, Silverstein M.

Ann Fam Med. 2016 Nov;14(6):503-508. doi: 10.1370/afm.1976.

40.

Effect of Tenapanor on Serum Phosphate in Patients Receiving Hemodialysis.

Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Åstrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM.

J Am Soc Nephrol. 2017 Jun;28(6):1933-1942. doi: 10.1681/ASN.2016080855. Epub 2017 Feb 3.

41.

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.

Locatelli F, Fishbane S, Block GA, Macdougall IC.

Am J Nephrol. 2017;45(3):187-199. doi: 10.1159/000455166. Epub 2017 Jan 25. Review.

42.

Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.

Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM.

JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468.

43.

Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.

Block GA, Bushinsky DA, Cunningham J, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Mix TC, Moe SM, Patel UD, Silver J, Spiegel DM, Sterling L, Walsh L, Chertow GM.

JAMA. 2017 Jan 10;317(2):146-155. doi: 10.1001/jama.2016.19456.

44.

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia.

Fishbane S, Block GA, Loram L, Neylan J, Pergola PE, Uhlig K, Chertow GM.

J Am Soc Nephrol. 2017 Jun;28(6):1851-1858. doi: 10.1681/ASN.2016101053. Epub 2017 Jan 12.

45.

Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.

Pasch A, Block GA, Bachtler M, Smith ER, Jahnen-Dechent W, Arampatzis S, Chertow GM, Parfrey P, Ma X, Floege J.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):315-322. doi: 10.2215/CJN.04720416. Epub 2016 Dec 9.

46.

Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis.

Wetmore JB, Liu J, Dluzniewski PJ, Ishani A, Block GA, Collins AJ.

BMC Surg. 2016 Nov 29;16(1):77.

47.

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.

Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ.

BMC Nephrol. 2016 Nov 4;17(1):166.

48.

Parent Perspectives on Their Mobile Technology Use: The Excitement and Exhaustion of Parenting While Connected.

Radesky JS, Kistin C, Eisenberg S, Gross J, Block G, Zuckerman B, Silverstein M.

J Dev Behav Pediatr. 2016 Nov/Dec;37(9):694-701.

PMID:
27802256
49.

Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis.

Bushinsky DA, Rossignol P, Spiegel DM, Benton WW, Yuan J, Block GA, Wilcox CS, Agarwal R.

Am J Nephrol. 2016;44(5):404-410. Epub 2016 Oct 27.

50.

Maternal diet quality before pregnancy and risk of childhood leukaemia.

Singer AW, Carmichael SL, Selvin S, Fu C, Block G, Metayer C.

Br J Nutr. 2016 Oct;116(8):1469-1478. Epub 2016 Oct 11.

PMID:
27725005

Supplemental Content

Support Center